These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 17200355)

  • 21. The Pro/Pro genotype at TP53 codon 72 polymorphism is associated with early onset glioblastoma.
    El Hallani S; Rossetto M; Sanson M
    Cancer Genet; 2012 Dec; 205(12):677. PubMed ID: 23228226
    [No Abstract]   [Full Text] [Related]  

  • 22. Negligible validation rate for public domain stop-codon SNPs.
    Sawyer SL; Berglind LC; Brookes AJ
    Hum Mutat; 2003 Sep; 22(3):252-4. PubMed ID: 12938090
    [No Abstract]   [Full Text] [Related]  

  • 23. Inherited variation in immune genes and pathways and glioblastoma risk.
    Schwartzbaum JA; Xiao Y; Liu Y; Tsavachidis S; Berger MS; Bondy ML; Chang JS; Chang SM; Decker PA; Ding B; Hepworth SJ; Houlston RS; Hosking FJ; Jenkins RB; Kosel ML; McCoy LS; McKinney PA; Muir K; Patoka JS; Prados M; Rice T; Robertson LB; Schoemaker MJ; Shete S; Swerdlow AJ; Wiemels JL; Wiencke JK; Yang P; Wrensch MR
    Carcinogenesis; 2010 Oct; 31(10):1770-7. PubMed ID: 20668009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intragenic breakpoint: a marker of genome instability in glioblastoma.
    Zheng S; Verhaak RG
    Cell Cycle; 2013 Dec; 12(24):3705-6. PubMed ID: 24145229
    [No Abstract]   [Full Text] [Related]  

  • 25. [Apoplectiform course of the disease in glioblastoma].
    ROTHE H
    Medizinische; 1954 Nov; 46():1545-9. PubMed ID: 13235113
    [No Abstract]   [Full Text] [Related]  

  • 26. A pilot study of physician personal preferences for treatment of glioblastoma.
    Chen CC; Depp C; Wilson B; Bartek J; Carter B
    Acta Neurochir (Wien); 2016 Oct; 158(10):1933. PubMed ID: 27541491
    [No Abstract]   [Full Text] [Related]  

  • 27. A pooled multisite analysis of the effects of atopic medical conditions in glioma risk in different ethnic groups.
    Krishnamachari B; Il'yasova D; Scheurer ME; Bondy M; Zhou R; Wrensch M; Davis F
    Ann Epidemiol; 2015 Apr; 25(4):270-4. PubMed ID: 25691445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and low-grade glioma: the emergence of genetic information.
    Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
    Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pooled multisite analysis of the effects of female reproductive hormones on glioma risk.
    Krishnamachari B; Il'yasova D; Scheurer ME; Bondy ML; Wrensch M; Davis FG
    Cancer Causes Control; 2014 Aug; 25(8):1007-13. PubMed ID: 24890803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic biomarkers of T-cells in human glioma.
    Wiencke JK; Accomando WP; Zheng S; Patoka J; Dou X; Phillips JJ; Hsuang G; Christensen BC; Houseman EA; Koestler DC; Bracci P; Wiemels JL; Wrensch M; Nelson HH; Kelsey KT
    Epigenetics; 2012 Dec; 7(12):1391-402. PubMed ID: 23108258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.
    Jenkins RB; Xiao Y; Sicotte H; Decker PA; Kollmeyer TM; Hansen HM; Kosel ML; Zheng S; Walsh KM; Rice T; Bracci P; McCoy LS; Smirnov I; Patoka JS; Hsuang G; Wiemels JL; Tihan T; Pico AR; Prados MD; Chang SM; Berger MS; Caron AA; Fink SR; Halder C; Rynearson AL; Fridley BL; Buckner JC; O'Neill BP; Giannini C; Lachance DH; Wiencke JK; Eckel-Passow JE; Wrensch MR
    Nat Genet; 2012 Oct; 44(10):1122-5. PubMed ID: 22922872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SSBP2 variants are associated with survival in glioblastoma patients.
    Xiao Y; Decker PA; Rice T; McCoy LS; Smirnov I; Patoka JS; Hansen HM; Wiemels JL; Tihan T; Prados MD; Chang SM; Berger MS; Kosel ML; Fridley BL; Lachance DH; O'Neill BP; Buckner JC; Thompson RC; Nabors LB; Olson JJ; Brem S; Madden MH; Browning JE; Wiencke JK; Egan KM; Jenkins RB; Wrensch MR
    Clin Cancer Res; 2012 Jun; 18(11):3154-62. PubMed ID: 22472174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
    Jenkins RB; Wrensch MR; Johnson D; Fridley BL; Decker PA; Xiao Y; Kollmeyer TM; Rynearson AL; Fink S; Rice T; McCoy LS; Halder C; Kosel ML; Giannini C; Tihan T; O'Neill BP; Lachance DH; Yang P; Wiemels J; Wiencke JK
    Cancer Genet; 2011 Jan; 204(1):13-8. PubMed ID: 21356187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
    Wrensch M; Jenkins RB; Chang JS; Yeh RF; Xiao Y; Decker PA; Ballman KV; Berger M; Buckner JC; Chang S; Giannini C; Halder C; Kollmeyer TM; Kosel ML; LaChance DH; McCoy L; O'Neill BP; Patoka J; Pico AR; Prados M; Quesenberry C; Rice T; Rynearson AL; Smirnov I; Tihan T; Wiemels J; Yang P; Wiencke JK
    Nat Genet; 2009 Aug; 41(8):905-8. PubMed ID: 19578366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total dietary antioxidant index and survival in patients with glioblastoma multiforme.
    Il'yasova D; Marcello JE; McCoy L; Rice T; Wrensch M
    Cancer Causes Control; 2009 Oct; 20(8):1255-60. PubMed ID: 19363672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between polymorphisms in DNA repair genes and glioblastoma.
    McKean-Cowdin R; Barnholtz-Sloan J; Inskip PD; Ruder AM; Butler M; Rajaraman P; Razavi P; Patoka J; Wiencke JK; Bondy ML; Wrensch M
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1118-26. PubMed ID: 19318434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.
    Scheurer ME; Amirian E; Cao Y; Gilbert MR; Aldape KD; Kornguth DG; El-Zein R; Bondy ML
    Clin Cancer Res; 2008 Oct; 14(20):6640-6. PubMed ID: 18927306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma.
    Potter N; Karakoula A; Phipps KP; Harkness W; Hayward R; Thompson DN; Jacques TS; Harding B; Thomas DG; Palmer RW; Rees J; Darling J; Warr TJ
    Neoplasia; 2008 Aug; 10(8):757-72. PubMed ID: 18670637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests.
    Chang JS; Yeh RF; Wiencke JK; Wiemels JL; Smirnov I; Pico AR; Tihan T; Patoka J; Miike R; Sison JD; Rice T; Wrensch MR
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1368-73. PubMed ID: 18559551
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.